ConductScience.org, home

Paper70733

Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues.

Gregoriadis G and 2 others. Life Sci, 1977. Cited by 102 papers, by iCite.

Cite this record

ConductScience Library. Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Papers, record 70733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/70733

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues.
PubMed
Journal
Life Sci
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
102
iCite
Relative citation ratio, by iCite
3.56
iCite
Revised in PubMed
2019-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gregoriadis GG
2Neerunjun DED E
3Hunt RR

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
LiposomesMajor topic
NeoplasmsMajor topic
Animals
Antibodies, Neoplasm
Carcinoma, Hepatocellular
Female
Immunoglobulin G
Indium
Kidney
Liver
Liver Neoplasms
Lung
Lung Neoplasms
Lymphoma, Non-Hodgkin
Male
Mice
Neoplasms, Experimental
Radioisotopes
Rats
Spleen

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.

PMIDTitleJournalYearIn PapersSource
28042337Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy.Theranostics2017https://conductscience.org/library/papers/28042337PubMed
27096954Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.Oncotarget2016https://conductscience.org/library/papers/27096954PubMed
20586481Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivo.ACS Nano2010https://conductscience.org/library/papers/20586481PubMed
8422696Organ distribution and antitumor activity of free and liposomal doxorubicin injected into the hepatic artery.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8422696PubMed
7680982Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.Drugs1993https://conductscience.org/library/papers/7680982PubMed
7378067Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.Biochem J1980https://conductscience.org/library/papers/7378067PubMed
7001454Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/7001454PubMed
6803776Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.Biochem J1981https://conductscience.org/library/papers/6803776PubMed
6364035Immunoglobulins as targeting agents for liposome encapsulated drugs.Pharm Weekbl Sci1983https://conductscience.org/library/papers/6364035PubMed
6176223Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.Biochem J1981https://conductscience.org/library/papers/6176223PubMed
3939479Animal viruses of economic importance: genetic variation, persistence, and prospects for their control.Pharmacol Ther1985https://conductscience.org/library/papers/3939479PubMed
3896138The potential use of liposome-mediated antiviral therapy.Antiviral Res1985https://conductscience.org/library/papers/3896138PubMed
3699065Tumor uptake of 67Ga-carrying liposomes.Eur J Nucl Med1986https://conductscience.org/library/papers/3699065PubMed
3489480Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.Br J Cancer1986https://conductscience.org/library/papers/3489480PubMed
389479Potential of liposomes as drug-carriers in cancer chemotherapy: a review.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/389479PubMed
284398Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/284398PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/70733

GET https://conductscience.org/api/papers/v1/70733/authors